Literature DB >> 27766637

Increased prevalence of potential right-to-left shunting in children with sickle cell anaemia and stroke.

Michael M Dowling1, Charles T Quinn2, Claudio Ramaciotti3, Julie Kanter4, Ifeyinwa Osunkwo5, Baba Inusa6, Rathi Iyer7, Janet L Kwiatkowski8, Clarissa Johnson9, Melissa Rhodes10, William Owen11, John J Strouse12, Julie A Panepinto13, Lynne Neumayr14, Sharada Sarnaik15, Patricia A Plumb16, Nomazulu Dlamini17, Fenella Kirkham18, Linda S Hynan19.   

Abstract

'Paradoxical' embolization via intracardiac or intrapulmonary right-to-left shunts (RLS) is an established cause of stroke. Hypercoagulable states and increased right heart pressure, which both occur in sickle cell anaemia (SCA), predispose to paradoxical embolization. We hypothesized that children with SCA and overt stroke (SCA + stroke) have an increased prevalence of potential RLS. We performed contrasted transthoracic echocardiograms on 147 children (aged 2-19 years) with SCA + stroke) mean age 12·7 ± 4·8 years, 54·4% male) and a control group without SCA or stroke (n = 123; mean age 12·1 ± 4·9 years, 53·3% male). RLS was defined as any potential RLS detected by any method, including intrapulmonary shunting. Echocardiograms were masked and adjudicated centrally. The prevalence of potential RLS was significantly higher in the SCA+stroke group than controls (45·6% vs. 23·6%, P < 0·001). The odds ratio for potential RLS in the SCA + stroke group was 2·7 (95% confidence interval: 1·6-4·6) vs controls. In post hoc analyses, the SCA + stroke group had a higher prevalence of intrapulmonary (23·8% vs. 5·7%, P < 0·001) but not intracardiac shunting (21·8% vs. 18·7%, P = 0·533). SCA patients with potential RLS were more likely to report headache at stroke onset than those without. Intrapulmonary and intracardiac shunting may be an overlooked, independent and potentially modifiable risk factor for stroke in SCA.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  cardiology; clinical research; sickle cell anaemia; stroke

Mesh:

Year:  2016        PMID: 27766637      PMCID: PMC5239723          DOI: 10.1111/bjh.14391

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  36 in total

1.  Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.

Authors:  Michael R DeBaun; Mae Gordon; Robert C McKinstry; Michael J Noetzel; Desiree A White; Sharada A Sarnaik; Emily R Meier; Thomas H Howard; Suvankar Majumdar; Baba P D Inusa; Paul T Telfer; Melanie Kirby-Allen; Timothy L McCavit; Annie Kamdem; Gladstone Airewele; Gerald M Woods; Brian Berman; Julie A Panepinto; Beng R Fuh; Janet L Kwiatkowski; Allison A King; Jason M Fixler; Melissa M Rhodes; Alexis A Thompson; Mark E Heiny; Rupa C Redding-Lallinger; Fenella J Kirkham; Natalia Dixon; Corina E Gonzalez; Karen A Kalinyak; Charles T Quinn; John J Strouse; J Philip Miller; Harold Lehmann; Michael A Kraut; William S Ball; Deborah Hirtz; James F Casella
Journal:  N Engl J Med       Date:  2014-08-21       Impact factor: 91.245

2.  Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke.

Authors:  Douglas J Scothorn; Cynthia Price; Daniel Schwartz; Cindy Terrill; George R Buchanan; Wanda Shurney; Ingrid Sarniak; Robert Fallon; Jen-Yih Chu; Charles H Pegelow; Winfred Wang; James F Casella; Linda S Resar; Brian Berman; Thomas Adamkiewicz; Lewis L Hsu; Kwaku Ohene-Frempong; Kim Smith-Whitley; Donald Mahoney; J Paul Scott; Gerald M Woods; Masayo Watanabe; Michael R Debaun
Journal:  J Pediatr       Date:  2002-03       Impact factor: 4.406

Review 3.  Intracardiac shunting and stroke in children: a systematic review.

Authors:  Michael M Dowling; Catherine M Ikemba
Journal:  J Child Neurol       Date:  2011-01       Impact factor: 1.987

Review 4.  Therapy insight: stroke risk and its management in patients with sickle cell disease.

Authors:  Fenella J Kirkham
Journal:  Nat Clin Pract Neurol       Date:  2007-05

5.  Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale.

Authors:  Vesa Karttunen; Leena Hiltunen; Vesa Rasi; Elina Vahtera; Matti Hillbom
Journal:  Blood Coagul Fibrinolysis       Date:  2003-04       Impact factor: 1.276

Review 6.  Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young.

Authors:  E Steve Roach; Meredith R Golomb; Robert Adams; Jose Biller; Stephen Daniels; Gabrielle Deveber; Donna Ferriero; Blaise V Jones; Fenella J Kirkham; R Michael Scott; Edward R Smith
Journal:  Stroke       Date:  2008-07-17       Impact factor: 7.914

7.  Patent foramen ovale and unexplained ischemic cerebrovascular events in children.

Authors:  Mirjana Perkovic Benedik; Marjan Zaletel; Nuska Pecaric Meglic; Tomaz Podnar
Journal:  Catheter Cardiovasc Interv       Date:  2007-12-01       Impact factor: 2.692

Review 8.  Hypercoagulability in sickle cell disease: a curious paradox.

Authors:  Kenneth I Ataga; Eugene P Orringer
Journal:  Am J Med       Date:  2003-12-15       Impact factor: 4.965

9.  Nontraumatic fat embolism syndrome in sickle cell anemia.

Authors:  D P Horton; D M Ferriero; W C Mentzer
Journal:  Pediatr Neurol       Date:  1995-01       Impact factor: 3.372

10.  Coagulation activation in children with sickle cell disease is associated with cerebral small vessel vasculopathy.

Authors:  Raffaella Colombatti; Emiliano De Bon; Antonella Bertomoro; Alessandra Casonato; Elena Pontara; Elisabetta Omenetto; Graziella Saggiorato; Agostino Steffan; Tamara Damian; Giuseppe Cella; Simone Teso; Renzo Manara; Patrizia Rampazzo; Giorgio Meneghetti; Giuseppe Basso; Maria Teresa Sartori; Laura Sainati
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240

View more
  14 in total

1.  Cerebral microhemorrhages and cerebral fat embolism in hemoglobin S-C disease.

Authors:  Sung-Min Cho; Geoffrey Ling; Lucia Rivera-Lara
Journal:  Neurol Clin Pract       Date:  2019-04

2.  Intracardiac or intrapulmonary shunts were present in at least 35% of adults with homozygous sickle cell disease followed in an outpatient clinic.

Authors:  Bryan C Hambley; Rania Abdul Rahman; Maxwell Reback; Mary Ann O'Riordan; Nathan Langer; Robert C Gilkeson; Mahazarin Ginwalla; Jane A Little; Robert Schilz
Journal:  Haematologica       Date:  2018-07-13       Impact factor: 9.941

Review 3.  Advances in Understanding Ischemic Stroke Physiology and the Impact of Vasculopathy in Children With Sickle Cell Disease.

Authors:  Kristin P Guilliams; Melanie E Fields; Michael M Dowling
Journal:  Stroke       Date:  2019-02       Impact factor: 7.914

4.  Quantification of whole-brain oxygenation extraction fraction and cerebral metabolic rate of oxygen consumption in adults with sickle cell anemia using individual T2 -based oxygenation calibrations.

Authors:  Wenbo Li; Xiang Xu; Peiying Liu; John J Strouse; James F Casella; Hanzhang Lu; Peter C M van Zijl; Qin Qin
Journal:  Magn Reson Med       Date:  2019-09-04       Impact factor: 4.668

5.  Sickle cell disease, fat embolism syndrome, and "starfield" pattern on MRI.

Authors:  Jennifer H Kang; Charles William Hargett; Theresa Sevilis; Matthew Luedke
Journal:  Neurol Clin Pract       Date:  2018-04

6.  Arteriopathy Influences Pediatric Ischemic Stroke Presentation, but Sickle Cell Disease Influences Stroke Management.

Authors:  Kristin P Guilliams; Fenella J Kirkham; Susanne Holzhauer; Steven Pavlakis; Bryan Philbrook; Catherine Amlie-Lefond; Michael J Noetzel; Nomazulu Dlamini; Mukta Sharma; Jessica L Carpenter; Christine K Fox; Marcela Torres; Rebecca N Ichord; Lori C Jordan; Michael M Dowling
Journal:  Stroke       Date:  2019-05       Impact factor: 7.914

7.  Spontaneous Pneumocephalus: An Incidental Finding With Prompt Resolution.

Authors:  Navila Sharif; Andrew Wilner
Journal:  Neurohospitalist       Date:  2021-08-12

8.  Diminished cerebral oxygen extraction and metabolic rate in sickle cell disease using T2 relaxation under spin tagging MRI.

Authors:  Adam M Bush; Thomas D Coates; John C Wood
Journal:  Magn Reson Med       Date:  2017-12-01       Impact factor: 4.668

9.  Vascular Instability and Neurological Morbidity in Sickle Cell Disease: An Integrative Framework.

Authors:  Hanne Stotesbury; Jamie M Kawadler; Patrick W Hales; Dawn E Saunders; Christopher A Clark; Fenella J Kirkham
Journal:  Front Neurol       Date:  2019-08-13       Impact factor: 4.003

10.  Identifying Clinical and Research Priorities in Sickle Cell Lung Disease. An Official American Thoracic Society Workshop Report.

Authors:  A Parker Ruhl; S Christy Sadreameli; Julian L Allen; Debra P Bennett; Andrew D Campbell; Thomas D Coates; Dapa A Diallo; Joshua J Field; Elizabeth K Fiorino; Mark T Gladwin; Jeffrey A Glassberg; Victor R Gordeuk; Leroy M Graham; Anne Greenough; Jo Howard; Gregory J Kato; Jennifer Knight-Madden; Benjamin T Kopp; Anastassios C Koumbourlis; Sophie M Lanzkron; Robert I Liem; Roberto F Machado; Alem Mehari; Claudia R Morris; Folasade O Ogunlesi; Carol L Rosen; Kim Smith-Whitley; Danna Tauber; Nancy Terry; Swee Lay Thein; Elliott Vichinsky; Nargues A Weir; Robyn T Cohen; Elizabeth S Klings
Journal:  Ann Am Thorac Soc       Date:  2019-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.